Drug Topics
OCTOBER 27, 2022
Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
IDStewardship
OCTOBER 27, 2022
In this article an infectious diseases pharmacist discusses antibiotic myths. Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 27 October 2022. Have you ever seen the show MythBusters on the Discovery Channel? Well this blog post is not nearly as cool as that show, but it may be a fun read at least! Here are 15 antibiotic myths to beware… Myth 1: Stopping antibiotic courses early leads to antibiotic resistance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
OCTOBER 26, 2022
A survey of more than 5,000 Americans conducted with Ipsos found that nearly 40% of insured Americans struggle to understand what their health insurance covers.
PharmaVoice
OCTOBER 26, 2022
The Stanford researcher and biotech entrepreneur discusses how click and bioorthogonal chemistry could revolutionize drug development.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 27, 2022
COVID-19 bivalent booster uptake has been very sluggish, even though the booster provides better protection against newer variants. What can pharmacists and their teams do to improve booster rates?
IDStewardship
OCTOBER 28, 2022
In this article a PGY2 Infectious Diseases Pharmacy Resident discusses social media as a resource for pharmacy residency recruitment, providing insights for both programs and candidates. . Authored by: Hunter O. Rondeau, Pharm.D. Article Posted 28 October 2022. Virtual recruitment for post-graduate residency programs continues to find its place, especially now with the upcoming in-person Midyear after two years of an “online-only” environment.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
OCTOBER 26, 2022
The VP of regulatory affairs and global patient safety explains why her line of work lets her do “a little of everything,” and the company’s plans to score a new approval for its blockbuster drug.
Drug Topics
OCTOBER 27, 2022
Offering immunization services at the pharmacy promotes public health and strengthens patient-pharmacy staff relationships.
Pharmacy Times
OCTOBER 26, 2022
Research suggests that positron emission tomography scans are effective at detecting early and late Hodgkin’s lymphoma, and the results could help manage and reduce toxicity from current chemotherapies.
PhRMA
OCTOBER 24, 2022
The bipartisan Bayh-Dole Act created a framework for researchers receiving federal funds to patent and license their inventions to companies for further development and commercialization. This benefits innovators across many sectors.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaVoice
OCTOBER 25, 2022
The company's head of U.S. and Canadian operations explains how the company is evolving its game plan after 100 years in the insulin space.
Drug Topics
OCTOBER 25, 2022
In a recent poll, only 1 in 5 parents believed it is unsafe for children to take medicine past its expiration date, while many did not know how to properly dispose medicine.
Pharmacy Times
OCTOBER 28, 2022
Modifications related to final product verifications, immunizations, and remote work loom on the horizon for 2023.
STAT
OCTOBER 28, 2022
There are increasing signs that flu season is off to a very early start in parts of the United States, with the cumulative hospitalization rate higher than it has been at this point in the fall for more than a decade, the Centers for Disease Control and Prevention reported Friday. In its weekly FluView report , the CDC estimated that there have already been 880,000 influenza illnesses, 6,900 flu hospitalizations, and 360 deaths caused by flu this season, which started at the beginning of October
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
PharmaVoice
OCTOBER 25, 2022
The company’s co-founder and head of R&D on how it’s using synthetic mRNA to create “smarter” therapies that could provide cures for cancer and more.
Drug Topics
OCTOBER 26, 2022
The Flip the Pharmacy program provides tools to pharmacy technicians and non-pharmacy support staff Mitchell’s Drug Stores to help provide patient care.
Pharmacy Times
OCTOBER 28, 2022
In a panel, pharmacy technicians discuss the future of pharmacy technicians in United States, Portugal, and the United Kingdom.
Pharmaceutical Technology
OCTOBER 28, 2022
Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Considering the low chances of success, with only 10% of drug candidates making it into clinical development, pharma companies must prevent the increased erosion of profit margins.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmaVoice
OCTOBER 27, 2022
Biogen and Eisai's new Alzheimer's drug is wowing investigators, and it might help the companies get past previous failures.
Drug Topics
OCTOBER 25, 2022
How on pharmacy helps patients with chronic concerns like diabetes.
Pharmacy Times
OCTOBER 27, 2022
Although clinicians cited lack of time as a reason for not using patient-reported outcomes, patients with HIV viewed their use very positively.
STAT
OCTOBER 28, 2022
The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned. One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT.
PharmaVoice
OCTOBER 28, 2022
Top women execs speak to the leadership skills they are embracing as the industry adjusts to a new normal.
Drug Topics
OCTOBER 28, 2022
State of Skin Sensitivity Report raises awareness of the causes of skin sensitivity and its effect on the mind.
Pharmacy Times
OCTOBER 25, 2022
News research results in Zambia also find that early intervention in the form of antiretroviral therapies and better nutrition may help close the gap.
pharmaphorum
OCTOBER 28, 2022
In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Join us on Wednesday 23rd November at 12:30 GMT / 13:30 CET / 7:30 am EST as the panel discuss how the Innovative Medicines Fund works, what the implications are for industry organisations in securing fu
PharmaVoice
OCTOBER 24, 2022
Why a ‘very exciting’ trial of the therapy in lupus patients could swing the door open to new studies in autoimmune diseases.
Drug Topics
OCTOBER 24, 2022
According to NEXGEL, the patch is expected be available for ophthalmologists to offer to their patients in the first half of 2023.
Pharmacy Times
OCTOBER 25, 2022
Patients with synchronous liver metastases from colorectal cancer have been found to have worse outcomes than those with metachronous liver metastases.
pharmaphorum
OCTOBER 25, 2022
Novartis has abandoned development of its drug to treat presbyopia, a common age-related loss of near distance vision, after it failed a phase 2b trial. The eyedrop formulation of UNR844 (lipoic acid/choline ester chloride) was acquired as part of the group’s buyout of privately-held ophthalmology biotech Encore Vision for $375 million upfront in 2017, and was designed to work by restoring the elasticity of the eye’s lens that declines with age.
PharmaVoice
OCTOBER 24, 2022
In Amgen's 2022 Biosimilars Trend Report, the company tracks the progress and potential of the copycat drugs as they reach a pivotal moment.
Drug Topics
OCTOBER 22, 2022
Results of multiple studies were presented at IDWeek 2022.
Pharmacy Times
OCTOBER 26, 2022
Food insecurity has previously been linked to adverse cardiovascular outcomes, but research is limited regarding the local food environment and the association with death from heart failure.
Expert insights. Personalized for you.
503 
Let's personalize your content